HLA-A*0201 & B2M & KRAS (KLVVVGAGGV)

HLA-A*0201 & B2M & KRAS (KLVVVGAGGV) Produktliste

Attribut
Protein (1)
Produktbibliothek
Online (1)
Spezies
Human (1)
Etikett
His Tag & Avi Tag (1)
Marker
Biotin-labeled (1)

Produktnummer	Spezies	Expressionssystem	Produktbeschreibung	Proteinstruktur	Reinheit	Eigenschaften	Vorbestellen/Bestellen
HLS-H82E4	Human	HEK293	Biotinylated Human HLA-A*02:01&B2M&KRAS (KLVVVGAGGV) Complex Protein (Monomer, MALS verified)				In den Warenkorb legen

Gesamtmenge1

HLA-A*0201 & B2M & KRAS (KLVVVGAGGV) Molekülhintergrund

The Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) oncogene plays a critical role in the initiation and maintenance of pancreatic tumors and its signaling network represents a major target for therapeutic intervention. The Human HLA-A*0201 KRAS (KLVVVGAGGV) complex protein is a complex of HLA-A*0201 of the MHC Class I, B2M, and KLVVVGAGGV peptide of the KRAS.

Klinische Arzneimittelinformation

Englischer Name	Forschungscode	Forschungsphase	Firma	Indikationen	Klinische Studie
IMVT-1402	HL-161 ANS; IMVT-1402	Phase 2 Clinical	Immunovant Sciences Gmbh, HanAll Biopharma Co Ltd	Autoimmune Diseases; Graves Disease	Details

Inverkehr gebrachte Arzneimittelinformation

Englischer Name	Forschungscode	Forschungsphase	Firma	Frühestes Markenname	Frühestes Genehmigungsland	Früheste Indikation	Früheste Genehmigungsgesellschaft	Früheste Genehmigungsdatum	Indikationen	Klinische Studie
Efgartigimod alfa	ARGX-113; EFG PH20; EFG PH20 SC; PH20 SC; ARGX-113-2308	Approved	Argenx Se	VYVGART HYTRULO, VYVDURA, VYVGART, 卫伟迦	United States	Myasthenia Gravis	Argenx BV	2021-12-17	Graves Ophthalmopathy; Tachycardia; Pemphigus; Thrombocytopenia; Guillain-Barre Syndrome; Eye Diseases; Nephrotic Syndrome; Muscular Diseases; Pemphigoid, Bullous; Optic Neuritis; Glomerulonephritis, Membranous; Rejection of organ transplantation; Purpura, Thrombocytopenic, Idiopathic; Lupus Nephritis; Scleroderma, Systemic; Stiff-Person Syndrome; Sjogren's Syndrome; Postural Orthostatic Tachycardia Syndrome; Polyneuropathies; Myositis; Nephrosis; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Myasthenia Gravis	Details
Rozanolixizumab	UCB-7665	Approved	Ucb Sa	RYSTIGGO	United States	Myasthenia Gravis	Ucb Inc	2023-06-27	Myasthenia Gravis; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Purpura, Thrombocytopenic, Idiopathic; Encephalitis; Fibromyalgia	Details
Efgartigimod alfa/Hyaluronidase		Approved	Argenx BV	VYVDURA, VYVGART HYTRULO	United States	Myasthenia Gravis	Argenx BV	2023-06-20	Myasthenia Gravis	Details